Loading…

Efficacy of ILIB on periodontal clinical parameters and glycemic control in patients with periodontitis and type II diabetes—randomized clinical trial

Our study aimed to study the efficacy of ILIB on periodontal parameters and glycemic control in patients with periodontitis and type II diabetes. Twenty-one patients in a randomized clinical trial were divided into 2 groups: control group (CG), conventional periodontal therapy, and test group (TG),...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in medical science 2022-04, Vol.37 (3), p.1945-1952
Main Authors: da Silva Júnior, Francisco Leonardo, de Araújo Silva, Davi Neto, da Silva Azevedo, Marcela Letícia, da Silva, Natália Teixeira, Almeida, Hursula Cardoso, da Silva, Regia Carla Medeiros, de Lima, Kenio Costa, da Silveira, Éricka Janine Dantas, de Aquino Martins, Ana Rafaela Luz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Our study aimed to study the efficacy of ILIB on periodontal parameters and glycemic control in patients with periodontitis and type II diabetes. Twenty-one patients in a randomized clinical trial were divided into 2 groups: control group (CG), conventional periodontal therapy, and test group (TG), conventional periodontal treatment associated with 10 laser applications by the ILIB-Modified (ILIB-M) technique. Fasting blood glucose levels and glycated hemoglobin (HbA1c), visible plaque index (VPI), gingival bleeding index (GBI), and periodontal clinical parameters were evaluated at baseline and after 4 months (T 4 ). Regarding periodontal parameters, the intragroup analysis showed a statistically significant reduction ( p   0.05) were observed between the TG and CG for the VPI, GBI, BOP, PD, and CAL indexes. Regarding HbA1C and fasting blood glucose values, no statistically significant improvements were observed in intergroup and intragroup analyses ( p  > 0.05). The Modified ILIB did not improve the periodontal clinical parameters and glycemic control in patients with type II diabetes.
ISSN:1435-604X
0268-8921
1435-604X
DOI:10.1007/s10103-021-03455-2